1. Market Research
  2. > Zimbabwe Pharmaceuticals and Healthcare Report Q3 2016

Zimbabwe Pharmaceuticals and Healthcare Report Q3 2016

  • July 2016
  • -
  • Business Monitor International
  • -
  • 69 pages

Includes 3 FREE quarterly updates

BMI View: Zimbabwe's ongoing economic crisis is continuing to take a toll on the country'spharmaceutical and healthcare sector. Severely underfunded public healthcare services and high povertylevels have made access to formal treatments difficult, with many turning to traditional healers instead.Despite government pledges to improve healthcare access in recent years, we have yet to see anysubstantial developments, with the country still heavily reliant on international aid for essential medicines.Further issues including a high abundance of counterfeit drugs and political instability make Zimbabwe oneof the least attractive markets in the region for multinational drugmakers.Headline Expenditure ProjectionsPharmaceuticals: USD380mn in 2015 to USD400mn in 2016; +4.7% in US dollar terms. Forecastunchanged from last quarter.

Table Of Contents

Zimbabwe Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Zimbabwe 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Zimbabwe 2012-2020) 13
Healthcare Market Forecast 14
Prescription Drug Market Forecast 16
Patented Drug Market Forecast 17
Generic Drug Market Forecast 18
Pharmaceutical Trade Forecast 19
Table: Pharmaceutical Trade Data And Forecasts (Zimbabwe 2014-2020) 21
Industry Risk/Reward Index 22
Middle East and Africa Risk/Reward Index - Q3 2016 22
Zimbabwe Risk/Reward Index 30
Rewards 30
Risks 30
Regulatory Review 32
Regulatory Regime 32
Intellectual Property Issues 34
Pricing And Reimbursement Regime 35
Market Overview 38
Healthcare Sector 39
Table: Zimbabwe: Healthcare Facilities 39
Research and Development 45
Clinical Trials 46
Epidemiology 46
Competitive Landscape 49
Research-Based Industry 49
Table: Multinational Market Activity 50
Generic Drugmakers 51
Pharmaceutical Distribution and Retail Sector 52
Company Profile 53
Datlabs 53
Varichem Laboratories 55
Demographic Forecast 58
Table: Population Headline Indicators (Zimbabwe 1990-2025) 59
Table: Key Population Ratios (Zimbabwe 1990-2025) 59
Table: Urban/Rural Population and Life Expectancy (Zimbabwe 1990-2025) 60
Table: Population By Age Group (Zimbabwe 1990-2025) 60
Table: Population By Age Group % (Zimbabwe 1990-2025) 61
Glossary 63
Methodology 65
Pharmaceutical Expenditure Forecast Model 65
Healthcare Expenditure Forecast Model 65
Notes On Methodology 66
Risk/Reward Index Methodology 67
Index Overview 68
Table: Pharmaceutical Risk/Reward Index Indicators 68
Indicator Weightings 69

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.